From lab to clinic : How AI can help
Published: March 4, 2020
2nd March 2020 – By Ulrik Kristensen, PhD, The Science Advisory Board contributing writer – Featured on The Science Advisory Board – Artificial intelligence (AI) and machine learning are becoming essential for biomedical research. From analyzing real-world data and scientific information to providing improved predictive outcomes, clinical trials are an important checkpoint in moving therapies from the lab to the clinic, and AI software can help researchers and clinicians reach their goals in several ways.
Click here to continue reading on scienceboard.net’s website…
Share on LinkedIn
AI in Drug Development & Clinical TrialsPublished December 2020.
AI in Drug Development & Clinical Trials
This is a brochure for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials published in December 2020.
Find out more